Related Experiment Video
Updated: Jun 26, 2025

06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.2K
Comparison of the prognosis among in-hospital survivors of cardiogenic shock based on etiology: AMI and Non-AMI
Shih-Chieh Chien1, Cheng-An Wang2, Hung-Yi Liu3
1Cardiovascular Division, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan.
Annals of Intensive Care
|May 12, 2024
Summary
Post-discharge outcomes for cardiogenic shock (CS) survivors are critical. Acute myocardial infarction (AMI)-CS survivors face higher short-term mortality and rehospitalization, while non-AMI-CS patients experience increased long-term mortality risk.
Area of Science:
- Cardiology
- Clinical Research
- Public Health
Background:
- Limited data exists on long-term mortality and rehospitalization rates for cardiogenic shock (CS) survivors.
- Understanding these outcomes is crucial for both acute myocardial infarction (AMI)-CS and non-AMI-CS patient groups.
Purpose of the Study:
- To investigate and compare post-discharge mortality and rehospitalization risks in survivors of AMI-CS versus non-AMI-CS.
- To identify specific risk factors and temporal trends in adverse events following hospital discharge.
Main Methods:
- A retrospective cohort study utilizing the Taiwan National Health Insurance Research Database.
- In-hospital CS survivors were followed for three years, with mortality and rehospitalization analyzed using Kaplan-Meier curves and Cox regression models.
Main Results:
- Overall mortality and rehospitalization rates were high, with cardiovascular issues accounting for a significant portion.
- Non-AMI-CS patients had higher initial mortality burden but lower adjusted risks for all-cause and CV mortality within the first year compared to AMI-CS.
- After one year, the mortality risk reversed, with non-AMI-CS patients exhibiting higher risks, while AMI-CS patients consistently showed higher risks for CV rehospitalization.
Conclusions:
- In-hospital AMI-CS survivors face elevated risks of CV rehospitalization and 30-day mortality.
- Non-AMI-CS survivors are at greater risk of mortality beyond the one-year follow-up mark.

